Skip to main content

Inlyta User Reviews & Ratings

Inlyta has an average rating of 9.0 out of 10 from a total of 1 reviews on 100% of reviewers reported a positive experience, while 0% reported a negative experience.

Condition Avg. Rating Reviews Compare
Renal Cell Carcinoma  
1 reviews for Renal Cell Carcinoma 21 medications
Add your review
  • NCano
  • Taken for 1 to 6 months
  • May 5, 2021

For Renal Cell Carcinoma "Husband is taking Inlyta now for @ 4 months. Visible tumors have reduced in size by almost half. Side effects that have shown up are Endocrine in nature: Adrenal glands reduced production, Feet Glands for corns and bone spurs, mucus membrane in sinus, loss of salivation production. Greater thirst is prevalent and additional fluid for intake to maintain hydration. Due to this, 2 additional pills introduced: Levothyroxine for Thyroid and Cortisone type (??name) for Adrenal gland function. Specialists now are: Oncologist, Endocrinologist, Podiatrist, Nephrologist (for the 1 remaining kidney), and his Primary Dr."

9 / 10
Was this helpful?YesNo
10 Report

Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.